Patents by Inventor Jérôme Gonzalez

Jérôme Gonzalez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10611970
    Abstract: The invention concerns a process and a facility for reducing the concentration of heavy polycyclic aromatic compounds (HPNA) in the recycle loop of hydrocracking units, which comprises a fractionation column. In accordance with this process, a portion of the stream present at the level of at least one plate located between the plate for supplying hydrocracked effluent and the plate for withdrawing the distillate fraction which is the heaviest is withdrawn from the fractionation column and at least a portion of said withdrawn stream is recycled to the column directly or after optional liquid separation, and optionally a portion of said withdrawn stream is recycled to the hydrocracking step directly or after optional gas separation.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: April 7, 2020
    Assignee: AXENS
    Inventors: Thibault Sauge, Roberto Gonzalez Llamazares, Jerome Bonnardot, Jacinthe Frecon
  • Patent number: 10533142
    Abstract: The invention concerns a process and a facility for reducing the concentration of heavy polycyclic aromatic compounds (HPNA) in the recycle loop of hydrocracking units, which comprises a fractionation column. In accordance with this process, a portion of the stream present at the level of at least one plate (I) which is the supply plate or a plate located between the supply plate and the residue evacuation point, or if stripping gas is injected, between the supply plate and the stripping gas injection point, is withdrawn from the fractionation column. A portion, preferably all, of the withdrawn stream is recycled to the hydrocracking step directly or after optional separation of the gases. The residue is purged in its entirety.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: January 14, 2020
    Assignee: AXENS
    Inventors: Thibault Sauge, Roberto Gonzalez Llamazares, Jerome Bonnardot, Jacinthe Frecon
  • Patent number: 10465127
    Abstract: The invention concerns a process and a facility for reducing the concentration of heavy polycyclic aromatic compounds (HPNA) in the recycle loop of hydrocracking units, which comprises a fractionation column. In accordance with this process, a stream is withdrawn from the fractionation column at the level of at least one plate located between the supply plate and the plate for withdrawing the heaviest distillate fraction; the stream is stripped in an external stripping step by a stripping gas, in the presence of a portion of the residue. The separated gaseous effluent is recycled to the column, advantageously as a stripping gas, and the liquid fraction is recycled to the hydrocracking step; a residue is purged in the stripping step.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: November 5, 2019
    Assignee: AXENS
    Inventors: Thibault Sauge, Roberto Gonzalez Llamazares, Jerome Bonnardot, Jacinthe Frecon
  • Patent number: 9185159
    Abstract: In process for modeling a display coming from an application on a server, the display being destined for a remote terminal, the display is modeled to compose an image according to display information coming from the application by stacked layers, each layer consisting of pixels and being associated with a corresponding first alteration data set, each pixel being characterized by a transparency factor of the pixel; the first alteration data set indicating characteristics of the layer connected with the alterations performed by the application, the resulting image consisting of image pixels and being associated with a second alteration data set, the second alteration data set indicating whether the image was altered due to the modification of the layers by the application, the image pixels being composed of the superimposed corresponding pixels of the layers.
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: November 10, 2015
    Assignee: CY-PLAY
    Inventors: David Libault, Jerome Gonzalez
  • Patent number: 9029405
    Abstract: The present invention provides compounds of Formula (I), as selective S1P1 inhibitors, as well as their use for treating multiple sclerosis and other diseases.
    Type: Grant
    Filed: July 6, 2011
    Date of Patent: May 12, 2015
    Assignee: Merck Serono S.A.
    Inventors: Agnes Bombrun, Anna Quattropani, Jerome Gonzalez, Jerome Dorbais, Chris Knight, Charles Baker-Glenn
  • Patent number: 8983549
    Abstract: A method of acquisition by a mobile terminal (20) situated in proximity to a display panel (10), of complementary information related to at least one poster (11) present on the display panel (10), the method including the following steps: acquisition of the identification data (S1) making it possible to identify the display panel (10), transmission of the identification data (S2) to a processing service by way of a communication network; and reception, from the processing service, of the complementary information relating to the poster (11) presented on the display panel (10) identified by the processing service on the basis of the identification data.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: March 17, 2015
    Inventors: Jerome Gonzalez, David Libault, Jacques Lewiner
  • Publication number: 20130116289
    Abstract: The present invention provides compounds of Formula (I), as selective S1P1 inhibitors, as well as their use for treating multiple sclerosis and other diseases.
    Type: Application
    Filed: July 6, 2011
    Publication date: May 9, 2013
    Applicant: MERCK SERONO S.A.
    Inventors: Agnes Bombrun, Anna Quattropani, Jerome Gonzalez, Jerome Dorbais, Chris Knight, Charles Baker-Glenn
  • Publication number: 20130029602
    Abstract: A method of acquisition by a mobile terminal (20) situated in proximity to a display panel (10), of complementary information related to at least one poster (11) present on the display panel (10), the method including the following steps: acquisition of the identification data (S1) making it possible to identify the display panel (10), transmission of the identification data (S2) to a processing service by way of a communication network; and reception, from the processing service, of the complementary information relating to the poster (11) presented on the display panel (10) identified by the processing service on the basis of the identification data.
    Type: Application
    Filed: April 1, 2011
    Publication date: January 31, 2013
    Inventors: Jerome Gonzalez, David Libault, Jacques Lewiner
  • Patent number: 8309579
    Abstract: The present invention is related to N-hydroxyamide derivatives of Formula (I) and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis.
    Type: Grant
    Filed: July 28, 2011
    Date of Patent: November 13, 2012
    Assignee: Merck Serono SA
    Inventors: Dominique Swinnen, Jerome Gonzalez
  • Patent number: 8247437
    Abstract: The present invention is related to N-hydroxyamide derivatives of Formula (I) and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis.
    Type: Grant
    Filed: June 8, 2011
    Date of Patent: August 21, 2012
    Assignee: Merck Serono SA
    Inventors: Dominique Swinnen, Agnes Bombrun, Jerome Gonzalez, Stefano Crosignani, Patrick Gerber, Catherine Jorand-Lebrun
  • Patent number: 8202865
    Abstract: The invention relates to compounds of formula I: wherein R1, R2, Ra, Rb, W, Q and S have the meanings given in claim 16. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.
    Type: Grant
    Filed: October 1, 2008
    Date of Patent: June 19, 2012
    Assignee: Merck Serono SA
    Inventors: Anna Quattropani, Cyril Montagne, Wolfgang Sauer, Stefano Crosignani, Agnes Bombrun, Mathilde Muzerelle, Jermone Dorbais, Delphine Marin, Jerome Gonzalez, Patrick Gerber
  • Patent number: 8198280
    Abstract: The present invention is related to N-hydroxyamide derivatives of Formula (I) and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis.
    Type: Grant
    Filed: December 16, 2010
    Date of Patent: June 12, 2012
    Assignee: Merck Serono SA
    Inventors: Dominique Swinnen, Jerome Gonzalez
  • Patent number: 8110574
    Abstract: A subject of the present application is new derivatives of 4-aminopiperidines of formula in which R1, R2 and R3 represent various radical, and their preparation processes by synthetic methods in parallel in liquid and solid phase. These products having a good affinity with certain sub-types of somatostatin receptors, they are particularly useful for treating the pathological states or diseases in which one (or more) somatostatin receptors are involved.
    Type: Grant
    Filed: November 15, 2010
    Date of Patent: February 7, 2012
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Christophe Thurieau, Jérôme Gonzalez, Christophe Moinet
  • Publication number: 20110281891
    Abstract: The present invention is related to N-hydroxyamide derivatives of Formula (I) and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis.
    Type: Application
    Filed: July 28, 2011
    Publication date: November 17, 2011
    Applicant: MERCK SERONO SA
    Inventors: Dominique SWINNEN, Jerome GONZALEZ
  • Publication number: 20110269508
    Abstract: In process for modeling a display coming from an application on a server, the display being destined for a remote terminal, the display is modeled to compose an image according to display information coming from the application by stacked layers, each layer consisting of pixels and being associated with a corresponding first alteration data set, each pixel being characterized by a transparency factor of the pixel; the first alteration data set indicating characteristics of the layer connected with the alterations performed by the application, the resulting image consisting of image pixels and being associated with a second alteration data set, the second alteration data set indicating whether the image was altered due to the modification of the layers by the application, the image pixels being composed of the superimposed corresponding pixels of the layers.
    Type: Application
    Filed: December 31, 2009
    Publication date: November 3, 2011
    Applicant: CY-PLAY
    Inventors: David Libault, Jerome Gonzalez
  • Publication number: 20110263628
    Abstract: The present invention is related to N-hydroxyamide derivatives of Formula (I) and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis.
    Type: Application
    Filed: June 8, 2011
    Publication date: October 27, 2011
    Applicant: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
    Inventors: Dominique Swinnen, Agnes Bombrun, Jerome Gonzalez, Stefano Crosignani, Patrick Gerber, Catherine Jorand-Lebrun
  • Patent number: 8008302
    Abstract: The present invention is related to N-hydroxyamide derivatives of Formula (I) and use thereof, in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis.
    Type: Grant
    Filed: July 25, 2005
    Date of Patent: August 30, 2011
    Assignee: Merck Serono SA
    Inventors: Dominique Swinnen, Agnes Bombrun, Jerome Gonzalez, Stefano Crosignani, Patrick Gerber, Catherine Jorand-Lebrun
  • Patent number: 7998964
    Abstract: The present invention is related to N-hydroxyamide derivatives of Formula (I) and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis.
    Type: Grant
    Filed: November 16, 2006
    Date of Patent: August 16, 2011
    Assignee: Merck Serono S.A.
    Inventors: Dominique Swinnen, Jerome Gonzalez
  • Patent number: 7947851
    Abstract: The present invention is related to carboxylic acids of Formula (I) and use thereof for the treatment and/or prevention of obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, polycystic ovary syndrome (PCOS). In particular, the present invention is related to the use of carboxylic acids of Formula (I) to modulate, notably to inhibit the activity of PTPs.
    Type: Grant
    Filed: March 29, 2005
    Date of Patent: May 24, 2011
    Assignee: Merck Serono SA
    Inventors: Dominique Swinnen, Catherine Jorand-Lebrun, Patrick Gerber, Jerome Gonzalez, Agnes Bombrun
  • Publication number: 20110086864
    Abstract: The present invention is related to N-hydroxyamide derivatives of Formula (I) and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis.
    Type: Application
    Filed: December 16, 2010
    Publication date: April 14, 2011
    Inventors: Dominique Swinnen, Jerome Gonzalez